Arch of Constantine | Vittoria Bridge | |
11:00 | Bleeding phenotype and target joints predict patients with zero bleeds given once-weekly rophylaxis with BAY94-9027 E. Musi (Switzerland) |
Evaluation of a fully–automated
chemiluminescent immunoassay for the rapid quantification of ADAMTS13
activity and the detection of ADAMTS13 inhibitors M. Mirabet (Spain) |
11:15 | Comparing the one-stage and
chromogenic assay: actor VIII activity assay discrepancy at baseline
does not eflect assay discrepancy after desmopressin in non-severe
hemophilia A patients. L. Schutte (the Netherlands) |
Immunoglobulin G subclass
distribution of anti-ADAMTS13 antibodies and its association with
HLA-DR-DQ haplotypes and clinical course in acquired thrombotic
thrombocytopenic purpura G. Sinkovits (Hungary) |
13:00 | BAY 1093884 target the Kunitz Domains 1 and 2 of TFPI and Blocks Its Function P. Mathew (USA) |
Congenital (hereditary) thrombotic
thrombocytopenic purpura (cTTP [hTTP], Upshaw–Schulman Syndrome):
Patient experience, conceptual framework, and patient-reported outcome
(PRO) instrument development B. Ewenstein (USA) |
13:15 | Nonacog beta pegol in adult andpaediatric patients: pooled data from the paradigm™ clinical programme M. Lapecorella (Italy) |
Unraveling anti-spacer immunoprofiles of acquired TTP patients using antiidiotypic antibodies A. S. Schelpe (Belgium) |
13:30 | Preliminary enrolment data from the U.S. post-marketing safety (PMS) study of rpFVIII in patients with acquired hemophilia R. Crea (Austria) |
Prevention of relapses in patients affected by acquired TTP undergoing elective surgery B. Ferrari (Italy) |
14:00 | Nonacog beta pegol for the
prophylactic treatment of children with hemophilia B: interim results
from the Paradigm™5 clinical trial M. Lapecorella (Italy) |
Possibile repeat time |
14:15 | Possibile repeat time | Possibile repeat time |
16:30 | Clustered F8 missense mutations cause
hemophilia A phenotypic heterogeneity by combination of altered
splicing, protein secretion and activity M. Pinotti (Italy) |
Diagnosis of Upshaw-Schulman syndrome in adulthood B. Ferrari (Italy) |
16:45 | Von Willebrand factor levels in patients with hemophilia A. M. Milos (Croatia) |
Modeling-guided identification of structural determinants contributing to conformational changes within ADAMTS13 B. Ercig (the Netherlands) |